Interethnic variability of plasma paraoxonase (PON1) activity towards organophosphates and PON1 polymorphisms among Asian populations - A short review

被引:26
作者
Ali, Safiyya Mohamed [2 ]
Chia, Sin Eng [1 ,2 ]
机构
[1] Natl Univ Singapore, Dept Community Occupat & Family Med, Singapore 117548, Singapore
[2] Natl Univ Singapore, Fac Med, Dept Community & Family Med MD3, Ctr Mol Epidemiol, Singapore 117597, Singapore
关键词
organophosphate; toxicity; paraoxonase; PON1; polymorphisms; Asia;
D O I
10.2486/indhealth.46.309
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Organophosphate (OP) poisoning is a progressively worrying phenomenon as worldwide pesticide production and consumption has doubled. On average, WHO estimates that 3% of agricultural workers in developing Asian countries suffer an episode of pesticide poisoning every year. Furthermore, the threat of OP usage in terrorism is existent, as seen by the subway tragedy in Tokyo in 1995 where sarin was used. Despite these alarming facts, there is currently no global system to track poisonings related to pesticide use. Human serum paraoxonase (PON1) is the enzyme that hydrolyses OP compounds. Serum PON1 levels and activity vary widely among different ethnic populations. Two commonly studied polymorphisms of PON1 are PON1Q192R and PON1L55M. PON1R192 hydrolyses paraoxon faster than PON1Q192 but hydrolyses diazoxon, sarin and soman eight times slower, and vice versa. PON1M55 has lower plasma levels of PON1 than PON1L55. As the prevalence of the different alleles and genotypic distribution vary between the Asian populations we studied, we propose the necessity to study PON1 polymorphisms and its role in OP toxicity in Asian populations. This would help safeguard the proper care of agricultural workers who might be affected by OP poisoning, and alert relevant anti biological terrorism agencies on possible risks involved in the event of an OP attack and provide effective counter measures.
引用
收藏
页码:309 / 317
页数:9
相关论文
共 65 条
[1]   The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns [J].
Antikainen, M ;
Murtomaki, S ;
Syvanne, M ;
Pahlman, R ;
Tahvanainen, E ;
Jauhiainen, M ;
Frick, MH ;
Ehnholm, C .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :883-885
[2]   Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R [J].
Aviram, M ;
Billecke, S ;
Sorenson, R ;
Bisgaier, C ;
Newton, R ;
Rosenblat, M ;
Erogul, J ;
Hsu, C ;
Dunlop, C ;
La Du, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1617-1624
[3]  
Blatter Garin Marie-Claude, 1997, Journal of Clinical Investigation, V99, P62
[4]   Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression [J].
Brophy, VH ;
Jampsa, RL ;
Clendenning, JB ;
McKinstry, LA ;
Jarvik, GP ;
Furlong, CE .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (06) :1428-1436
[5]   Polymorphisms in the human paraoxonase (PON1) promoter [J].
Brophy, VH ;
Hastings, MD ;
Clendenning, JB ;
Richter, RJ ;
Jarvik, GP ;
Furlong, CE .
PHARMACOGENETICS, 2001, 11 (01) :77-84
[6]   Overcoming apathy in research on organophosphate poisoning [J].
Buckley, NA ;
Roberts, D ;
Eddleston, M .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7476) :1231-1233
[7]   Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus [J].
Cao, HB ;
Girard-Globa, A ;
Serusclat, A ;
Bernard, S ;
Bondon, P ;
Picard, S ;
Berthezene, F ;
Moulin, P .
ATHEROSCLEROSIS, 1998, 138 (02) :361-366
[8]   Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip [J].
Cherry, N ;
Mackness, M ;
Durrington, P ;
Povey, A ;
Dippnall, M ;
Smith, T ;
Mackness, B .
LANCET, 2002, 359 (9308) :763-764
[9]  
Costa Lucio G, 2005, Acta Biomed, V76 Suppl 2, P50
[10]   The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin [J].
Davies, HG ;
Richter, RJ ;
Keifer, M ;
Broomfield, CA ;
Sowalla, J ;
Furlong, CE .
NATURE GENETICS, 1996, 14 (03) :334-336